Ofirmev (acetaminophen) injection available

Cadence Pharmaceuticals announced the launch of Ofirmev (acetaminophen) injection for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever. Ofirmev first received FDA approval in November 2010.

For more information call (877) 647-2239 or visit www.ofirmev.com.